Market Tracker

03/24 5:16pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

29.93
Delayed Data
As of Mar 24
 +0.25 / +0.84%
Today’s Change
8.00
Today|||52-Week Range
63.73
+9.11%
Year-to-Date
Market Is Home on the Range Again
Mar 22 / TheStreet.com - Paid Partner Content
Sarepta's DMD Drug Launch Slow; What's in Store for 2017?
Mar 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.68
Today’s open29.72
Day’s range29.54 - 30.17
Volume856,246
Average volume (3 months)2,422,849
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+46.96%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc+0.24+2.60%
GBTGlobal Blood Therape...+0.60+1.56%
CBMCambrex Corp-0.45-0.88%
AERIAerie Pharmaceutical...+0.25+0.55%
Data as of 4:14pm ET, 03/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Chief Financial Officer &
Senior Vice President
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts